Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single-Arm Phase II Study.

Charles J, Belbezier A, Mouret S, Dreno B, Dalle S, Lebbe C, Hainaut-Wierzbicka E, Stefan A, de Quatrebarbes J, Dereure O, Zehou O, Mansard S, Dupuy A, Dutriaux C, Grange F, Gaudy-Marqueste C, Montaudié H, Arnault JP, Le Corre Y, Kervarrec T, Quesada JL, Samimi M, Leccia MT, Group of Cutaneous Oncology of the French Society of Dermatology

Open source

DOI: 10.1002/cam4.72295
Published: 2026 Oct
Container: Cancer medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cam4.72295,
  title = {Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single-Arm Phase II Study.},
  author = {Charles J and Belbezier A and Mouret S and Dreno B and Dalle S and Lebbe C and Hainaut-Wierzbicka E and Stefan A and de Quatrebarbes J and Dereure O and Zehou O and Mansard S and Dupuy A and Dutriaux C and Grange F and Gaudy-Marqueste C and Montaudié H and Arnault JP and Le Corre Y and Kervarrec T and Quesada JL and Samimi M and Leccia MT and Group of Cutaneous Oncology of the French Society of Dermatology},
  year = {2026},
  journal = {Cancer medicine},
  doi = {10.1002/cam4.72295},
  url = {https://doi.org/10.1002/cam4.72295}
}

RIS

TY  - JOUR
TI  - Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single-Arm Phase II Study.
AU  - Charles J
AU  - Belbezier A
AU  - Mouret S
AU  - Dreno B
AU  - Dalle S
AU  - Lebbe C
AU  - Hainaut-Wierzbicka E
AU  - Stefan A
AU  - de Quatrebarbes J
AU  - Dereure O
AU  - Zehou O
AU  - Mansard S
AU  - Dupuy A
AU  - Dutriaux C
AU  - Grange F
AU  - Gaudy-Marqueste C
AU  - Montaudié H
AU  - Arnault JP
AU  - Le Corre Y
AU  - Kervarrec T
AU  - Quesada JL
AU  - Samimi M
AU  - Leccia MT
AU  - Group of Cutaneous Oncology of the French Society of Dermatology
PY  - 2026
JO  - Cancer medicine
DO  - 10.1002/cam4.72295
UR  - https://doi.org/10.1002/cam4.72295
ER  -

APA

J, C., A, B., S, M., B, D., S, D., C, L., E, H., A, S., J, D. Q., O, D., O, Z., S, M., A, D., C, D., F, G., C, G., H, M., JP, A., Y, L. C., T, K., JL, Q., M, S., MT, L., & Dermatology, G. O. C. O. O. T. F. S. O. (2026). Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single-Arm Phase II Study.. Cancer medicine. https://doi.org/10.1002/cam4.72295

Source records

pubmed · retrieved 2026-09-26T18:12:20.460Z